Table 1 Distribution of different clinicopathological data of the studied prostatic carcinoma cases (N = 100)
Parameters | N (%) |
|---|---|
Age (years) | |
 > 65 | 64 (64%) |
 < 65 | 36 (36%) |
Primary tumor (pT) | |
pT2 | 56 (56%) |
pT3 | 44 (44%) |
LN | |
Positive | 42 (42%) |
Negative | 58 (58%) |
Stage | |
I | 12 (12%) |
II | 24 (24%) |
III | 48 (48%) |
IV | 16 (16%) |
Gleason grade group | |
Group 1 | 10 (10%) |
Group 2 | 4 (4%) |
Group 3 | 10 (10%) |
Group 4 | 38 (38%) |
Group 5 | 38 (38%) |
PSA level | |
 < 4 ng/ml | 6 (6%) |
4–10 ng/ml | 56 (56%) |
 < 10 ng/ml | 38 (38%) |
Capsular invasion | |
Present | 36 (36%) |
Absent | 64 (64%) |
LVI | |
Present | 34 (34%) |
Absent | 66 (66%) |
Perineural invasion | |
Present | 52 (52%) |
Absent | 48 (48%) |